We are live on ! Find out more
MNOV icon

MediciNova

15 hedge funds and large institutions have $5.25M invested in MediciNova in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

15% more funds holding

Funds holding: 1315 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less capital invested

Capital invested by funds: $5.53M → $5.25M (-$285K)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.49%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
2
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

MNOV Hedge Fund Activity: Q3 2013 in Review

15 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q3 2013, worth a combined $5.25M — down 5.2% from $5.53M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new MNOV positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $100K. The largest seller was Macquarie Group, exiting entirely with an estimated $323K sold.

  • 15 institutional investors held MediciNova (MNOV) as of Q3 2013, up from 13 in Q2 2013.
  • Funds reported $5.25M of MediciNova stock for Q3 2013, down 5.2% quarter-over-quarter.
  • 3 funds opened new MediciNova positions in Q3 2013 and 1 closed out, a net change of +2 holders.
  • The largest MediciNova buyer in Q3 2013 was Bridgeway Capital Management, an estimated $100K added.
  • The largest MediciNova seller in Q3 2013 was Macquarie Group, an estimated $323K sold.

Based on aggregated 13F filings for Q3 2013.